Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
ImmunoGen (IMGN) Q1 Earnings and Sales Outpace Estimates
03:21pm, Monday, 09'th May 2022 Zacks Investment Research
ImmunoGen (IMGN) reports a narrower-than-expected loss for first-quarter 2022. It also beats revenue estimates.
Alcon (ALC) to Report Q1 Earnings: What's in the Cards?
03:05pm, Monday, 09'th May 2022 Zacks Investment Research
Strength in Vision Care with the addition of new products and recent acquisition is likely to have contributed to Alcon's (ALC) first-quarter performance.
STERIS (STE) to Report Q4 Earnings: What's in the Cards?
02:56pm, Friday, 06'th May 2022 Zacks Investment Research
Strength in Healthcare and AST arms is expected to have driven STERIS' (STE) fourth-quarter revenues.
10 Marijuana Stocks Lighting Up With a Focus on Earnings
01:23pm, Friday, 06'th May 2022
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will co
What 6 Analyst Ratings Have To Say About Jazz Pharmaceuticals
05:12pm, Thursday, 05'th May 2022 Benzinga
Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
4
1
0
0
JAZZ Q1 Earnings Miss, Sales Robust, 2022 Guidance Raised
02:32pm, Thursday, 05'th May 2022 Zacks Investment Research
JAZZ's product revenues grow in the first quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. It raises guidance on strong results.
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
12:43pm, Thursday, 05'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
FDA Approval For AstraZeneca-Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast Cancer
The�
JAZZ Q1 Earnings Miss, Sales Robust, 2022 Guidance Raised
12:02pm, Thursday, 05'th May 2022
JAZZ's product revenues grow in the first quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. It raises guidance on strong results.
Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q1 2022 Results - Earnings Call Transcript
12:50am, Thursday, 05'th May 2022
Jazz Pharmaceuticals plc (NASDAQ:JAZZ ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Andrea Flynn – Head-Investor Relations Bruce Cozadd – Chairman and Chief Execut
Jazz Pharmaceuticals (JAZZ) Lags Q1 Earnings and Revenue Estimates
10:05pm, Wednesday, 04'th May 2022 Zacks Investment Research
Jazz (JAZZ) delivered earnings and revenue surprises of -0.53% and 4.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Jazz Pharmaceuticals (JAZZ) Lags Q1 Earnings and Revenue Estimates
07:33pm, Wednesday, 04'th May 2022
Jazz (JAZZ) delivered earnings and revenue surprises of -0.53% and 4.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Onconova (ONTX) to Report Q1 Earnings: What's in the Cards?
05:00pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Investors will watch for updates on its lead candidate narazaciclib when Onconova Therapeutics. (ONTX) reports first-quarter earnings.
Jazz Pharmaceuticals to Participate in the BofA Securities 2022 Global Healthcare Conference
04:15pm, Tuesday, 03'rd May 2022
DUBLIN , May 3, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the BofA Securities 2022 Global Healthcare Conference on Tuesday, May
Viatris (VTRS) to Report Q1 Earnings: What's in the Cards?
04:10pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Viatris' (VTRS) Q1 earnings might have been adversely impacted by competition in the complex generics business.
The Best Marijuana Stocks In 2022 And The Different Cannabis Sectors To Watch Right Now
05:00pm, Sunday, 01'st May 2022
The Cannabis Industry And Parts Of The Sector To Watch In 2022 The post The Best Marijuana Stocks In 2022 And The Different Cannabis Sectors To Watch Right Now appeared first on Marijuana Stocks | Can
